Many cases are drug-resistant, leaving people with limited treatment options. Researchers at Mayo Clinic found that low-frequency DBS not only reduced seizures, but it also improved memory and sleep.

News Release 22-Sep-2022 Mayo Clinic researchers identify drug resistance factors for advanced prostate cancer Peer-Reviewed Publication Mayo Clinic ROCHESTER, Minn.

In a statement, Mayo Clinic said it will continue to provide coverage of these weight loss medications through the employee medical plan "with a new provision that reflects a lifetime maximum ...

Mayo Clinic will limit coverage for weight loss drugs through its employee health plan starting in 2024, the Post Bulletin reported Nov. 11. The Mayo Medical Plan, administered by Medica, will ...

Study involving investigators from Mayo Clinic, Baylor College of Medicine applies drug-gene testing to improve patient care and reports outcomes Peer-Reviewed Publication Mayo Clinic ...

Rochester, Md.-based Mayo Clinic has announced a partnership with leading pharmaceutical manufacturer Baxter and the biotech arm of Velocity Pharmaceutical Development, a bioscience development ...

Mayo Clinic’s Florida campus in Jacksonville will receive $12 million and manage the distribution of the remaining grant to its collaborators in the study. The experimental drug is called ibudilast.

Many cases are drug-resistant, leaving people with limited treatment options. Researchers at Mayo Clinic found that low-frequency DBS not only reduced seizures, but it also improved memory and sleep.

The Mayo Clinic Biobank is a collection of samples, including blood and blood derivatives, and health information donated by Mayo Clinic patients. Seventy-seven genes known to be involved in drug ...

The new generic drug company, Civica Rx, will include a spectrum of governing members including Minnesota's Mayo Clinic health system, several Catholic and secular nonprofit hospital systems, and ...